Delivery Order SPE2DR25D1103-SPE2DR26FD836
- Not listed
- The Defense Logistics Agency awarded a Delivery Order valued at $1,498.56 to AmerisourceBergen Drug Corp for the supply of Dextroamphetamine-Amphetamine 20 mg capsules (100 count) on November 5, 2025, with completion scheduled for November 6, 2025. This non-competitive, firm fixed-price delivery order was fulfilled from AmerisourceBergen's location in Conshohocken, Pennsylvania, representing a routine pharmaceutical procurement under the company's existing contract vehicle with DLA. This...
- The Defense Logistics Agency awarded a delivery order valued at $1,170.56 to AmerisourceBergen Drug Corp for 100 capsules of dextroamphetamine-amphetamine 30 mg on September 16, 2025, with completion targeted for September 17, 2025. This competitively awarded, non-set-aside contract reflects a firm fixed price arrangement and represents a single delivery order under AmerisourceBergen's larger pharmaceutical supply vehicle with DLA. The pharmaceutical products will be delivered to the company's...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $3,062.60 for 100 capsules of Dextroamphetamine-Amphetamine 20 mg on April 24, 2025, with an ultimate completion date of April 25, 2025. This competitively awarded, firm fixed-price contract requires performance at AmerisourceBergen's facility in Conshohocken, Pennsylvania. The delivery order was issued without a set-aside designation, reflecting open competition among qualified pharmaceutical...
- The Defense Logistics Agency awarded a Delivery Order valued at $1,940.06 to AmerisourceBergen Drug Corp for the supply of Dextroamphetamine-Amphetamine 10 mg capsules (100-count units) on August 12, 2025, with completion scheduled for August 13, 2025. This firm fixed price, non-set-aside contract was performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania. The delivery order represents a child contract executed under a larger Indefinite Delivery Contract vehicle with DLA Troop...
- The U.S. Defense Logistics Agency Medical Supply Chain awarded AmerisourceBergen Drug Corp a delivery order valued at $1,966.33 for 100 capsules of Dextroamphetamine-Amphetamine 30 mg on August 7, 2025. This competitive, non-set-aside contract utilizes firm fixed pricing and is scheduled for completion by August 8, 2025. The order will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a delivery order valued at $1,954.77 to AmerisourceBergen Drug Corp for the supply of Dextroamphetamine-Amphetamine 10 mg capsules (100 count) on November 6, 2025, with an ultimate completion date of November 7, 2025. This firm fixed-price delivery order was awarded competitively with no set-aside designation and will be performed at the contractor's location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and...
- The Defense Logistics Agency awarded a delivery order valued at $1,291.32 to AmerisourceBergen Drug Corp for the supply of Dextroamphetamine-Amphetamine 10 mg capsules (100 count) on August 12, 2025, with an ultimate completion date of August 13, 2025. This is a firm fixed price delivery order with no set-aside designation, indicating it was competitively awarded. The pharmaceutical supply will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This...
- The Defense Logistics Agency issued a delivery order valued at $2,193.92 to AmerisourceBergen Drug Corp for 100 capsules of dextroamphetamine-amphetamine 20 mg. The contract, awarded June 30, 2025, with completion by July 1, 2025, employs firm fixed-price pricing with no set-aside designation, indicating competitive award. Performance will occur at AmerisourceBergen's Conshohocken, Pennsylvania location, the company's corporate headquarters. This delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on October 20, 2025, for the supply of Dextroamphetamine-Amphetamine 10 mg capsules (100 count) valued at $1,122.42. This competitively awarded, firm fixed-price delivery order is expected to be completed by October 21, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The contract does not utilize a set-aside designation and represents a child delivery...
- The Defense Logistics Agency awarded a delivery order valued at $2,220.67 to AmerisourceBergen Drug Corp for 100 capsules of Dextroamphetamine-Amphetamine 30 mg on September 19, 2025, with an ultimate completion date of September 22, 2025. This firm fixed-price, non-set-aside delivery order will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award represents a small-value pharmaceutical procurement supporting federal medical supply needs...
- SPE2DR25D1103Indefinite Delivery Contract
- SPE2DR25D1103-SPE2DR26FD836Delivery Order
The Defense Logistics Agency awarded a $1,422.00 delivery order to AmerisourceBergen Drug Corp for 100 capsules of Dextroamphetamine-Amphetamine 10 mg on November 10, 2025, with completion scheduled for November 12, 2025. This is a firm fixed-price, competitively awarded contract with no set-aside designation. The place of performance is AmerisourceBergen's corporate headquarters in Conshohocken, Pennsylvania. This delivery order represents a small-value transaction within the company's broader federal pharmaceutical supply portfolio. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, valued at $999,999,999.00 and extending through December 2026. This prime contract vehicle enables AmerisourceBergen to supply a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally, including specialty medications, brand-name and generic drugs, vaccines, and related medical commodities across multiple therapeutic domains. The contract supports customers including the Defense Health Agency and other federal government healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.4k | 11/10/25 |